Study proteins that may worsen fluid leaks in shock
Part of Brain & nervous system, Heart & circulation, Infections clinical trials.
This trial studies specific body proteins to understand why fluid can leak from blood vessels during dangerous shock after infection or heart problems. If you (or your representative) qualify, your team will collect information and possibly samples to see whether these proteins relate to recovery and treatment response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or a legal representative/family member) can give consent to join
- You are covered by the French social security system (not AME)
- You are an adult (18 or older) and not pregnant
- You have a serious circulation problem called shock, such as septic shock, cardiogenic shock, or after cardiac arrest
- You need medicines to keep blood pressure up (vasopressor or similar), and your blood lactate is above 2.0
- Your shock started within the last 12 hours (medicine started), not more than 12 hours before joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
This trial tests a new way to see if giving more fluids helps patients with septic shock, a severe infection that drops blood pressure. It uses a quick heart ultrasound to check if fluids will improve blood flow, aiming to guide better treatment.
This trial tests a special fluid management strategy for people in septic shock—a serious infection that causes very low blood pressure. It aims to improve blood flow to organs and help you recover.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.
This study tests an investigational fluid called VBI-S to see if it can help raise blood pressure in people with septic shock who are not responding to standard fluids. You may qualify if you have severe infection and low blood pressure that needs medication support.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.